HilleVax Statistics

Total Valuation

HilleVax has a market cap or net worth of $102.46 million. The enterprise value is -$33.55 million.

Market Cap	102.46M
Enterprise Value	-33.55M

Important Dates

The last earnings date was Wednesday, August 6, 2025, after market close.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

HilleVax has 49.50 million shares outstanding. The number of shares has increased by 8.00% in one year.

Current Share Class	49.50M
Shares Outstanding	49.50M
Shares Change (YoY)	+8.00%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	3.75%
Owned by Institutions (%)	45.76%
Float	27.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.69
P/TBV Ratio	0.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 26.39, with a Debt / Equity ratio of 0.16.

Current Ratio	26.39
Quick Ratio	25.96
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28.25

Financial Efficiency

Return on equity (ROE) is -40.31% and return on invested capital (ROIC) is -15.31%.

Return on Equity (ROE)	-40.31%
Return on Assets (ROA)	-14.48%
Return on Invested Capital (ROIC)	-15.31%
Return on Capital Employed (ROCE)	-31.02%
Revenue Per Employee	n/a
Profits Per Employee	-$5.08M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.19% in the last 52 weeks. The beta is 0.77, so HilleVax's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	+30.19%
50-Day Moving Average	2.03
200-Day Moving Average	1.89
Relative Strength Index (RSI)	51.19
Average Volume (20 Days)	830,207

Short Selling Information

The latest short interest is 444,024, so 0.90% of the outstanding shares have been sold short.

Short Interest	444,024
Short Previous Month	458,687
Short % of Shares Out	0.90%
Short % of Float	1.62%
Short Ratio (days to cover)	3.06

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-52.35M
Pretax Income	-156.27M
Net Income	-71.10M
EBITDA	-50.91M
EBIT	-52.35M
Earnings Per Share (EPS)	-$1.43

Full Income Statement

Balance Sheet

The company has $159.55 million in cash and $23.54 million in debt, giving a net cash position of $136.01 million or $2.75 per share.

Cash & Cash Equivalents	159.55M
Total Debt	23.54M
Net Cash	136.01M
Net Cash Per Share	$2.75
Equity (Book Value)	147.82M
Book Value Per Share	2.99
Working Capital	156.09M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$59.52 million and capital expenditures -$322,000, giving a free cash flow of -$59.84 million.

Operating Cash Flow	-59.52M
Capital Expenditures	-322,000
Free Cash Flow	-59.84M
FCF Per Share	-$1.21

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HilleVax does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.00%
Shareholder Yield	-8.00%
Earnings Yield	-69.39%
FCF Yield	-58.40%

Analyst Forecast

The average price target for HilleVax is $2.00, which is -3.38% lower than the current price. The consensus rating is "Hold".

Price Target	$2.00
Price Target Difference	-3.38%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2